Cell and Gene Logistics

  1. What's In The Leukopak Matters For Cell Therapy Manufacturing 10/11/2024

    Advanced cell-based therapies are impossible without high-quality leukopaks from high-quality donors.

  2. 4 Ways To Safeguard Your Supply Of Fetal Bovine Serum 10/10/2024

    A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain.

  3. How Elixirgen Manufactures Hematopoietic Stem Cells At The Bedside 10/9/2024

    The company uses a mobile manufacturing system to produce autologous stem cell therapy for patients with dyskeratosis congenita and other telomere biology disorders.

  4. Deamidation Drives AAV9 Potency Loss 10/8/2024

    This study aims to identify the cause of AAV9 potency loss observed during short-term storage at elevated temperatures and long-term refrigeration.

  5. Automated Cryopreservation Process For Leukapheresis Supports CGT Supply Chain 10/2/2024

    Uncover how this optimized process ensures consistency in cell viability and recovery while preserving immune cell populations across multiple donor samples.

  6. Enabling The Outcome In EMEA 10/2/2024

    With our global network of facilities and services, Cryoport Systems is a strategic partner of choice for temperature-controlled supply chain management of critical materials.

  7. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  8. Point-Of-Care, Decentralized CAR-T Manufacturing 9/13/2024

    In this Cell & Gene Live segment, our panelists deliberate on the feasibility of decentralized, point-of-care CAR-T manufacturing and highlight the common concerns and challenges associated with POC manufacturing.

  9. Decentralization Of Cell And Gene Therapy 9/4/2024

    Through case studies, examples, and patient testimonials, readers will gain insights into how decentralization can improve patient access, enhance treatment outcomes, and facilitate innovation.

  10. Are You Ready For The Coming Wave Of Regulatory Compliance? 9/3/2024

    The COVID-19 pandemic exposed critical vulnerabilities in medical product supply chains, highlighting the need for robust regulatory compliance. Prepare your facility for future regulatory scrutiny by strengthening your compliance and quality management practices.